期刊文献+

人源抗狂犬病毒单链二硫键稳定抗体的重组设计与表达 被引量:3

Recombinant design and expression of human anti-rabies virus ScdsFv
下载PDF
导出
摘要 以人源抗狂犬病毒糖蛋白母本单链抗体ScFv为模板,利用PCR点突变分别在重链FR可变区VH(44)和轻链FR可变区VL(100)分别引入一个半胱氨酸,成功构建了重组单链二硫键稳定抗体基因。连接pET22b(+)载体,转化入E.coli BL21(DE3)得到工程菌,IPTG诱导表达。体外复性并经Ni-NTA亲和层析对目的蛋白ScdsFv进行纯化;利用荧光抗体实验和ELISA检测抗体活性及稳定性。结果表明重组ScdsFv蛋白实现了原核高效表达,通过体外复性和Ni-NTA柱纯化获得纯度大于90%的ScdsFv蛋白。荧光抗体实验和ELISA结果表明ScdsFv具有特异的抗原结合活性,与母本ScFv比较,稳定性有明显提高。这种具有特异抗原结合活性的稳定ScdsFv蛋白的获得为其进一步的功能研究提供了材料。 To constructed the recombinant human anti-rabies virus ScdsFv, cys sites were introduced into framework region (FR) of VH and VL genes which were amplified from human anti-rabies virus ScFv respectively using genetic point mutation technology. Cloned the ScdsFv gene into expression vector pET22b( + ) and transformed into E. coli BL21 (DE3). The target protein was expressed by inducing with IPTG. Followed by renaturation in vitro and purified by NiNTA. The binding activity of ScdsFv was identified by Fluorescent antibody test (FAT) and ELISA. Results showed that recombinant ScdsFv were expressed at high level. Purity of the protein 〉 90% after purified by Ni-NTA and renaturaton in vitro. FAT and ELISA results demonstrated that ScdsFv could binding antigen specificity and was more stable than ScFv. Recombinant ScdsFv provided experiment materials for further functional study.
出处 《微生物学报》 CAS CSCD 北大核心 2007年第4期673-676,共4页 Acta Microbiologica Sinica
关键词 狂犬病毒 单链二硫键稳定抗体 表达 Rabies virus ScdsFv expression
  • 相关文献

参考文献3

二级参考文献30

  • 1韩秀娟,李薇.应用间接混合酶免疫试验方法测定麻疹抗体[J].中国生物制品学杂志,1994,7(4):169-171. 被引量:2
  • 2陈西贵,江德华,刘尚明,宋光荣.ELISA用于人类狂犬疫苗免疫效果现场监测的研究[J].中国卫生检验杂志,1994,4(5):289-291. 被引量:4
  • 3文洁,任雅萍,周学良.ELISA用于人血清抗狂犬病毒抗体的检测[J].中国人兽共患病杂志,1989,5(6):7-9. 被引量:17
  • 4团体著者,1990年
  • 5朱家鸿,病毒学报,1985年,1卷,2期,133页
  • 6李雪翔,中华流行病学杂志,1984年,5卷,4期,216页
  • 7林放涛,狂犬病学,1992年
  • 8Jung SH, Pastan I, Lee B. Design of interchain disulfide bonds in the framework region of the Fv fragment of the monoclonal antibody B3. Proteins 1994; 19:35-47.
  • 9Brinkmann U, Reiter Y, Jung SH, Lee B, Pastan I. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proc Natl Acad Sci USA 1993; 90:7538-7542.
  • 10Dohlsten M, Lando PA, Bjork P, Abrahmsen L, Ohlsson L,Lind P, Kalland T. Immunotherapy of human colon cancer by antibody-targeted superantigens. Cancer Immunol Immunother 1995; 41:162-168.

共引文献22

同被引文献69

  • 1陈媛媛,李永进,毕利军.基于表面等离子共振的新型生物传感技术及其在生命科学中的应用[J].生物物理学报,2006,22(2):82-88. 被引量:11
  • 2贾茜,徐葛林,赵伟,吴杰,郑新雄.重组人抗狂犬病病毒单抗SO57、SOJB对不同狂犬病病毒毒株中和作用的研究[J].病毒学报,2006,22(4):256-261. 被引量:8
  • 3Graham J H, Gottwald T R, Cubero J, Achor D S. Xanthomonas axonopodis pv. citri: factors affecting successful eradication of citrus canker. Molecular Plant Pathology, 2004, 5(1): 1 - 15.
  • 4Huston J S, Levinson D, Mudgett-Hunter M, Tai M S, Novotny J, Margolies M N, Ridge R J, Bruccoleri R E, Haber E, Crea R, Opermann H. Protein engineering of antibody binding sites: recovery of specific activity in an anti-doxigenin single chain Fv analogue produced in Escherichia coli. Proceedings of the National Academy of Sciences of the USA, 1988, 85(16): 5879-5883.
  • 5Buchner J, Pastan I, Brinkmann U. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Analytical Biochemistry, 1992, 205(2): 263-270.
  • 6Reiter Y, Kurucz I, Brinkmann U, Jung S H, Lee B, Segal D M, Pastan I. Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure. Immunity, 1995, 2(3): 281-287.
  • 7Glockshuber R, Malia M, Pfitzinger I, Pliickthun A. A comparison of strategies to stabilize immunoglobulin Fv fragments. Biochemistry, 1990, 29(6): 1362-1367.
  • 8Webber K O, Reiter Y, Brinkmann U, Kreitman R J, Pastan I. Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog. Molecular Immunology, 1995, 32(4): 249-258.
  • 9Brinkmann U, Reiter Y, Jung S H, Lee B, Pastan I. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Proceedings of the National Academy of Sciences of the USA, 1993, 90(16): 7538-7542.
  • 10Reiter Y, Brinkmann U, Kreitman R J, Jung S H, Lee B, Pastan I. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions. Biochemistry, 1994, 33(18): 5451-5459.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部